In today’s briefing:
- China Healthcare Weekly (Jul.7) – New NRDL Negotiation Rules, Assisted Reproduction Payment, Kintor
China Healthcare Weekly (Jul.7) – New NRDL Negotiation Rules, Assisted Reproduction Payment, Kintor
- NHSA released the new NRDL negotiation rules of innovative drugs. Some adjustments will bring certain benefits to innovative drugs, but the overall impact will not be as good as expected.
- Beijing announced that 16 assisted reproduction technologies will be covered by medical insurance reimbursement from July 1. This policy should benefit companies in the assisted reproduction industry chain.
- We analyzed the key flaws of Kintor Pharmaceutical (9939 HK), and we remain skeptical about this company.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
